Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20060247693 A1
Publication typeApplication
Application numberUS 11/116,558
Publication dateNov 2, 2006
Filing dateApr 28, 2005
Priority dateApr 28, 2005
Also published asUS8145310, US20080275522, US20120165895
Publication number11116558, 116558, US 2006/0247693 A1, US 2006/247693 A1, US 20060247693 A1, US 20060247693A1, US 2006247693 A1, US 2006247693A1, US-A1-20060247693, US-A1-2006247693, US2006/0247693A1, US2006/247693A1, US20060247693 A1, US20060247693A1, US2006247693 A1, US2006247693A1
InventorsYanting Dong, Scott Meyer, Kevin Stalsberg
Original AssigneeYanting Dong, Meyer Scott A, Stalsberg Kevin J
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Non-captured intrinsic discrimination in cardiac pacing response classification
US 20060247693 A1
Abstract
Cardiac devices and methods discriminate non-captured intrinsic beats during evoked response detection and classification by comparing the features of a post-pace cardiac signal with expected features associated with a non-captured response with intrinsic activation. Detection of a non-captured response with intrinsic activation may be based on the peak amplitude and timing of the cardiac signal. The methods may be used to discriminate between a fusion or capture beat and a non-captured intrinsic beat. Discriminating between possible cardiac responses to the pacing pulse may be useful, for example, during automatic capture verification and/or a capture threshold test.
Images(8)
Previous page
Next page
Claims(22)
1. A method of classifying a cardiac response to a pacing pulse, comprising:
delivering the pacing pulse to a heart;
sensing a cardiac signal following delivery of the pacing pulse;
comparing one or more characteristics of the cardiac signal to one or more expected cardiac signal characteristics associated with a non-captured response with intrinsic activity; and
classifying the cardiac response to the pacing pulse as the noncaptured response with intrinsic activation based on the comparison.
2. The method of claim 1, wherein comparing the cardiac signal characteristics to the expected characteristics comprises extracting features of the cardiac signal and comparing the features to expected cardiac signal features associated with the non-captured response with intrinsic activity.
3. The method of claim 2, wherein comparing the one or more features of the cardiac signal to the one or more expected features associated with the non-captured response with intrinsic activation comprises determining if one or more peaks of the cardiac signal respectively fall within one or more intrinsic detection windows, each of the one or more intrinsic detection windows associated with an intrinsic peak amplitude range and an intrinsic peak timing interval.
4. The method of claim 1, wherein classifying the cardiac response further comprises discriminating the non-captured response with intrinsic activation from unknown cardiac activity.
5. The method of claim 1, wherein classifying the cardiac response further comprises discriminating between a captured response and the non-captured response with intrinsic activation.
6. The method of claim 5, wherein discriminating between the captured response and the non-captured response with intrinsic activation comprises classifying the cardiac response as the captured response if one or more features of the cardiac signal are consistent with expected features associated with the captured response.
7. The method of claim 1, wherein classifying the cardiac response further comprises discriminating the cardiac response as a fusion beat if the cardiac response does not comprise a captured beat or a non-captured intrinsic beat.
8. The method of claim 1, wherein classifying the cardiac response to the pacing pulse comprises classifying the cardiac response to the pacing pulse during automatic capture verification.
9. The method of claim 1, wherein classifying the cardiac response to the pacing pulse comprises classifying the cardiac response to the pacing pulse during a capture threshold test.
10. The method of claim 1, further comprising:
sensing for a cardiac signal peak in at least two capture detection windows, each of the at least two capture detection windows associated with a captured response peak amplitude range and a captured response peak time interval; and
classifying the cardiac response as a captured response if the cardiac signal peaks are detected in the at least two capture detection windows.
11. The method of claim 10, further comprising classifying the cardiac response as fusion if the cardiac response does not comprise a non-captured intrinsic response or a captured response.
12. The method of claim 1, further comprising:
sensing for the cardiac signal peak in at least one noise detection window, the at least one noise detection window associated with a noise window amplitude range and a noise window time interval; and
classifying the cardiac response as unknown cardiac signal behavior if the cardiac signal peak is detected in the at least one noise detection window.
13. A system for classifying a cardiac response to a pacing pulse, comprising:
a sensor system, comprising a plurality of electrodes electrically coupled to a heart, the sensor system configured to sense a cardiac signal following delivery of the pacing pulse; and
a processor coupled to the sensing system, the processor configured to compare one or more characteristics of the cardiac signal to one or more expected cardiac signal characteristics associated with a non-captured intrinsic beat, and to classify the cardiac response to the pacing pulse as the non-captured intrinsic beat based on the comparison.
14. The system of claim 13, wherein the one or more characteristics of the cardiac signal comprise one or more features of the cardiac signal and the one or more expected characteristics comprise one or more expected characteristics and the processor is configured to extract the one or more features from the cardiac signal and to compare the extracted features to the one or more expected features.
15. The system of claim 14, wherein the one or more extracted features comprises a peak time of the cardiac signal and the one or more expected features comprises an expected peak timing range.
16. The system of claim 14, wherein the one or more extracted features comprises a peak amplitude of the cardiac signal and the one or more expected features comprises an expected peak amplitude range.
17. The system of claim 13, wherein the processor is configured to discriminate the non-captured intrinsic beat from other cardiac activation based on the one or more characteristics of the cardiac signal.
18. The system of claim 13, wherein the processor is configured to classify the cardiac response as the non-captured intrinsic beat if a cardiac signal peak is detected in at least one intrinsic detection window, the at least one intrinsic detection window associated with an intrinsic beat amplitude range and an intrinsic beat time interval relative to the cardiac signal.
19. The system of claim 18, wherein parameters of the at least one intrinsic detection window are selected based on an expected timing of a cardiac signal feature associated with a captured response.
20. The system of claim 18, wherein parameters of the at least one intrinsic detection window are selected based on patient conditions.
21. A cardiac device, comprising:
a pulse generator configured to deliver a pacing pulse to a heart;
a sensing system configured to sense a cardiac signal following delivery of the pacing pulse;
means for comparing one or more features of the cardiac signal to one or more expected features associated with a non-captured response with intrinsic activation; and
means for classifying the cardiac response to the pacing pulse as the non-captured response with intrinsic activation based on the comparison.
22. The cardiac device of claim 21, further comprising means for determining if a peak amplitude of the cardiac signal falls within an intrinsic detection window, the intrinsic detection window associated with an intrinsic peak amplitude range and an intrinsic peak timing interval.
Description
FIELD OF THE INVENTION

The present invention relates generally to implantable medical devices and, more particularly, to cardiac devices and methods that discriminate non-captured intrinsic beats during evoked response detection.

BACKGROUND OF THE INVENTION

When functioning normally, the heart produces rhythmic contractions and is capable of pumping blood throughout the body. However, due to disease or injury, the heart rhythm may become irregular resulting in diminished pumping efficiency. Arrhythmia is a general term used to describe heart rhythm irregularities arising from a variety of physical conditions and disease processes. Cardiac rhythm management systems, such as implantable pacemakers and cardiac defibrillators, have been used as an effective treatment for patients with serious arrhythmias. These systems typically include circuitry to sense electrical signals from the heart and a pulse generator for delivering electrical stimulation pulses to the heart. Leads extending into the patient's heart are connected to electrodes that contact the myocardium for sensing the heart's electrical signals and for delivering stimulation pulses to the heart in accordance with various therapies for treating the arrhythmias.

Cardiac rhythm management systems operate to stimulate the heart tissue adjacent to the electrodes to produce a contraction of the tissue. Pacemakers are cardiac rhythm management systems that deliver a series of low energy pace pulses timed to assist the heart in producing a contractile rhythm that maintains cardiac pumping efficiency. Pace pulses may be intermittent or continuous, depending on the needs of the patient. There exist a number of categories of pacemaker devices, with various modes for sensing and pacing one or more heart chambers.

When a pace pulse produces a contraction in the heart tissue, the electrical cardiac signal preceding the contraction is denoted the captured response (CR). The captured response typically includes an electrical signal, denoted the evoked response signal, associated with the heart contraction, along with a superimposed signal associated with residual post pace polarization at the electrode-tissue interface. The magnitude of the residual post pace polarization signal, or pacing artifact, may be affected by a variety of factors including lead polarization, after-potential from the pace pulse, lead impedance, patient impedance, pace pulse width, and pace pulse amplitude, for example.

A pace pulse must exceed a minimum energy value, or capture threshold, to produce a contraction. It is desirable for a pace pulse to have sufficient energy to stimulate capture of the heart without expending energy significantly in excess of the capture threshold. Thus, accurate determination of the capture threshold is required for efficient pace energy management. If the pace pulse energy is too low, the pace pulses may not reliably produce a contractile response in the heart and may result in ineffective pacing. If the pace pulse energy is too high, the patient may experience discomfort and the battery life of the device will be shorter.

Detecting if a pacing pulse “captures” the heart and produces a contraction allows the cardiac rhythm management system to adjust the energy level of pace pulses to correspond to the optimum energy expenditure that reliably produces capture. Further, capture detection allows the cardiac rhythm management system to initiate a back-up pulse at a higher energy level whenever a pace pulse does not produce a contraction.

A fusion beat is a cardiac contraction that occurs when two cardiac depolarizations of a particular chamber, but from separate initiation sites, merge. At times, a depolarization initiated by a pacing pulse may merge with an intrinsic beat, producing a fusion beat. Fusion beats, as seen on electrocardiographic recordings, exhibit various morphologies. The merging depolarizations of a fusion beat do not contribute evenly to the total depolarization.

Pseudofusion occurs when a pacing stimulus is delivered on a spontaneous P wave during atrial pacing or on a spontaneous QRS complex during ventricular pacing. In pseudofusion, the pacing stimulus may be ineffective because the tissue around the electrode has already spontaneously depolarized and is in its refractory period.

Noise presents a problem in evoked response detection processes when the pacemaker mistakenly identifies noise as capture, fusion/pseudofusion, or intrinsic activity. Noise mistakenly identified as capture or fusion/pseudofusion may cause a pacemaker to erroneously withhold backup pacing under loss of capture conditions. Noise mistakenly identified as non-captured intrinsic activity may lead to a premature loss of capture determination during threshold testing.

In the event that the pace does not capture the heart and capture or fusion/pseudofusion would then not occur, intrinsic activity may occur early enough in the cardiac cycle to appear as an evoked response when the pace did not actually capture the heart. These non-captured intrinsic beats represent a loss of capture. The misclassification of non-captured intrinsic beat to capture or fusion beats may result in low threshold measurement during threshold testing.

SUMMARY OF THE INVENTION

The present invention involves various cardiac devices and methods that discriminate non-captured intrinsic beats during evoked response detection and classification. An embodiment of a method of classifying a cardiac response to a pacing pulse in accordance with the present invention involves delivering pacing pulse to a heart and sensing a cardiac signal following delivery of the pacing pulse. The cardiac response to the pacing pulse is classified as a non-captured intrinsic beat based on one or more characteristics of the cardiac signal. Classifying the cardiac response may involve detecting one or both of a peak time and peak amplitude of the cardiac signal, and may be based on one or both of the peak time and peak amplitude.

Other embodiments of methods of classifying a cardiac response to a pacing pulse in accordance with the present invention involve sensing for a cardiac signal peak in at least one intrinsic beat detection window associated with an intrinsic beat amplitude range and an intrinsic beat time interval. The cardiac response may be classified as a non-captured intrinsic beat if the cardiac signal peak is detected in at least one intrinsic beat detection window. Methods may further involve sensing for a cardiac signal peak in at least two capture detection windows, each associated with a captured response amplitude range and a captured response time interval. The cardiac response may be classified as a captured response if the cardiac signal peaks are detected in at least two capture detection windows. Further, the cardiac response may be classified as fusion if the cardiac signal peak is not detected in at least one capture detection window, and the cardiac signal peak is not detected in the at least one intrinsic detection window.

Other embodiments of a method of classifying a cardiac response to a pacing pulse in accordance with the present invention involve sensing for the cardiac signal peak in at least one noise detection window associated with a noise window amplitude range and a noise window time interval. The cardiac response may be classified as an unknown cardiac signal behavior if the cardiac signal peak is detected in the at least one noise detection window.

Further embodiments in accordance with the present invention are directed to systems for classifying a cardiac response to a pacing pulse. Systems in accordance with the present invention may include a sensor system configured to sense a cardiac signal following delivery of the pacing pulse with a processor coupled to the sensing system. The processor may be configured to detect one or more features of the cardiac signal and to classify the cardiac response to the pacing pulse as a non-captured intrinsic beat based on the one or more cardiac signal features. The processor may be configured to detect one or more peak times and/or amplitudes of the cardiac signal and to classify the cardiac response based on the peak time(s) and/or amplitude(s). The processor may discriminate the non-captured intrinsic beat from other cardiac activity based on the one or more features of the cardiac signal. The processor may classify the cardiac response as the non-captured intrinsic beat if a feature value associated with a particular cardiac signal feature is consistent with an expected feature value associated with a non-captured intrinsic beat.

The above summary of the present invention is not intended to describe each embodiment or every implementation of the present invention. Advantages and attainments, together with a more complete understanding of the invention, will become apparent and appreciated by referring to the following detailed description and claims taken in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a flowchart of a method that discriminates non-captured intrinsic beats during evoked response detection and classification in accordance with embodiments of the invention;

FIG. 2 is a diagram illustrating time intervals that may be used for discriminating non-captured intrinsic beats during evoked response detection and classification in accordance with embodiments of the invention;

FIG. 3 is a graph including cardiac response classification windows and noise detection windows that may be utilized for cardiac devices and methods that discriminate non-captured intrinsic beats during evoked response detection and classification in accordance with embodiments of the invention;

FIG. 4 illustrates cardiac response waveform portions superimposed over the graph in FIG. 3 in accordance with embodiments of the invention;

FIG. 5 is a partial view of one embodiment of an implantable medical device in accordance with embodiments of the invention;

FIG. 6 is a block diagram of an implantable medical device that may be use for discrimination of non-captured intrinsic beats during evoked response detection and classification in accordance with embodiments of the invention; and

FIG. 7 is a schematic diagram of a circuit that may be used to sense a cardiac signal following the delivery of a pacing stimulation and to classify the cardiac response to the pacing stimulation according to embodiments of the invention.

While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail below. It is to be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.

DETAILED DESCRIPTION OF VARIOUS EMBODIMETS

In the following description of the illustrated embodiments, references are made to the accompanying drawings forming a part hereof, and in which are shown by way of illustration, various embodiments by which the invention may be practiced. It is to be understood that other embodiments may be utilized, and structural and functional changes may be made without departing from the scope of the present invention.

Cardiac response classification may be implemented by a pacemaker or other cardiac rhythm management (CRM) device to determine whether an applied electrical pacing stimulus captures the heart. Embodiments of the invention are directed to cardiac devices and methods that discriminate non-captured intrinsic beats during cardiac pacing response determination. The methods described herein use one or more characteristics of the cardiac signal, e.g., cardiac signal features, samples, discrete and/or analog morphological waveform characteristics, to discriminate between various responses to pacing and may be used during automatic capture verification or capture threshold testing. Cardiac pacing responses may include, for example, noncapture, capture, fusion/pseudofusion, and noncapture with intrinsic activity.

Processes for recognizing the cardiac response to pacing may rely on one or more templates characterizing various types of possible responses. The system may compare a cardiac signal sensed after delivery of the pacing pulse to the templates. If the cardiac signal is sufficiently similar to a particular template, then the cardiac response may be classified as the type of response characterized by the template.

In some embodiments, a template characterizing a particular type of cardiac pacing response may comprise one or more detection windows that represent an expected range of values of a cardiac signal associated with particular type of cardiac response. For example, if the cardiac signal following the pacing pulse is detected within the detection regions, then the system classifies the cardiac response as the particular type of cardiac response characterized by the template.

Automatic threshold and automatic capture verification are algorithms that may be used by cardiac rhythm management (CRM) devices. These algorithms attempt to discriminate captured beats from non-captured beats. Detection of non-capture may be complicated by non-capture beats that include intrinsic activation. For some patients, for example, patients with intact AV conduction, a non-captured beat with intrinsic activation may have a morphology somewhat similar to a captured response. Thus, templates used to discriminate between a captured response and a noncaptured response with intrinsic activation must be formed and used accurately to discriminate between the two types of responses. In automatic threshold testing, erroneous classification of a noncaptured intrinsic beat as a captured response may cause the capture threshold to be incorrectly identified.

Embodiments of the present invention are directed to detection and classification of non-captured beats with intrinsic activation. Detection and classification of such beats may be accomplished by recognizing the characteristic signal features of such non-captured intrinsic beats. In accordance with one aspect of the invention, detection and classification of non-captured, intrinsic beats is accomplished based on the determination of one or more features of the cardiac signal, for example, one or more peak amplitudes and associated peak times.

A template for recognizing the intrinsic beats may comprise one or more intrinsic detection windows, having dimensions of time and amplitude, into which peaks of the non-captured, intrinsic signal are expected to fall. If the peaks of a sensed cardiac signal fall into one or more of the intrinsic detection windows, the cardiac response may be classified as a non-captured response with intrinsic activation. Methods and systems for generating and updating detection windows, aspects of which may be utilized in connection with the embodiments of the present invention are described in commonly owned U.S. patent applications identified by Attorney Docket Nos.: GUID.168PA and GUID.169PA, both of which are concurrently filed with this patent application, and incorporated herein by reference.

One embodiment of the invention is based on the peak amplitude and timing of non-captured intrinsic activity, relative to those of captured beats. As will be described in more detail below, non-captured intrinsic beats typically have a relatively late peak relative to captured beats, while fusion beats typically have earlier peaks. Devices and methods in accordance with the present invention provide a non-captured intrinsic detection window after a capture detection window, to discriminate these non-captured intrinsic beats. In addition to the relatively late peak, an intrinsic beat may also have a larger peak amplitude when compared to the peak amplitude of a captured response. Therefore, embodiments of the present invention may include a second non-captured intrinsic detection window that may be used to discriminate non-captured intrinsic beats with increased peak amplitudes.

A further check may be performed to discriminate and manage unusual intrinsic beats, such as premature ventricular contraction (PVC). For example, one or more noise detection windows may also be provided in accordance with the present invention to detect a relatively large positive peak associated with PVC and uncommon to the other cardiac responses.

FIG. 1 is a flowchart of a method 100 of detecting non-captured beats with intrinsic activation in accordance with embodiments of the invention. Pacing pulses 110 are delivered to a patient's heart. For example, the pacing pulses may be delivered to one or more of a right ventricle, right atrium, left ventricle, and/or left atrium. Cardiac signals 120 following the pacing pulse that are associated with, or in response to, the pacing pulse are sensed, and measurements are made of one or more characteristics of the cardiac signal, such as cardiac signal features that may include amplitudes and timings associated with positive and/or negative cardiac signal peaks. The one or more cardiac signal characteristics are compared 130 to one or more expected characteristics associated with a non-captured response with intrinsic activation. If the one or more sensed cardiac signal characteristics are consistent with the one or more expected characteristics, the cardiac pacing response is classified 140 as a non-captured response with intrinsic activation.

FIG. 2 is a diagram illustrating multiple time intervals that may be used for discriminating non-captured intrinsic beats during cardiac pacing response classification in accordance with embodiments of the invention. A pacing stimulation 210 is delivered to the heart, for example, to the right ventricle. The cardiac signal is blanked for a period of time 220, typically about 0 milliseconds to about 40 milliseconds, following the delivery of the pacing stimulation 210. After the blanking period 220, a first time interval 230 is initiated. The duration of the first time interval 230 may be a programmable duration, for example, less than about 325 milliseconds. The cardiac signal associated with the pacing pulse is sensed during the first time interval 230. If the positive or negative amplitude of the cardiac signal does not exceed a threshold in the first time interval 230, then the cardiac response may be classified as a noncaptured response. If the cardiac signal exceeds the threshold value, then various features of the cardiac signal may be determined and used for cardiac pacing response classification. In some cases, sensing of the cardiac signal may be extended to additional time intervals, such as the second time interval 240. The second time interval 240 may be programmable, and may have a duration less than about 325 milliseconds. The durations of the additional time intervals may be different or the same as the duration of the first time interval.

A delay period 250 may be established between the end of one time interval 230 and the beginning of another time interval 240. The duration of the delay may be in a range of about 0 milliseconds (no delay) to about 40 milliseconds, for example. The cardiac response to the pacing stimulation 210 may be classified based on characteristics of the cardiac signal determined in the first and/or the additional time intervals 230, 240.

FIG. 3 illustrates detection windows that may be utilized in cardiac devices and methods that discriminate non-captured intrinsic beats during cardiac pacing response classification in accordance with embodiments of the invention. Following delivery of a pace 410, the sensing system is blanked, e.g., the sense electrodes are disconnected from sense amplifiers or the sense amplifiers are rendered inoperative, during a blanking period 415. Following the blanking period, the cardiac signal is sensed in one or more time intervals. As illustrated in FIG. 3, sensing may occur in two time intervals 420, 450 following the pacing pulse 410. In some scenarios, the second 450 and subsequent time intervals (not shown) may be triggered by events occurring in one or more previous intervals.

In various implementations, sensing may be performed using the same electrode combination that was used to deliver the pacing stimulation. In other implementations, the pacing stimulation may be delivered using a first electrode configuration and sensing may use a second electrode configuration. Use of a sensing vector that is spatially removed from the pacing vector may be particularly useful for diminishing the effect of a pacing artifact on the cardiac signal following pacing. Systems and methods for classifying a cardiac response to pacing using multiple time intervals and various sensing and pacing vectors are described in commonly owned U.S. Patent applications: Ser. No. 10/733,869, filed Dec. 11, 2003, entitled “Cardiac Response Classification Using Multiple Classification Windows”; Ser. No. 10/734,599 filed Dec. 12, 2003, entitled “Cardiac Response Classification Using Retriggerable Classification Windows”; and Ser. No. 10/735,519 filed Dec. 12, 2003, entitled “Cardiac Response Classification Using Multisite Sensing And Pacing”; which are hereby incorporated herein by reference.

During the first time interval 420, the system senses for a positive or negative cardiac signal amplitude beyond a threshold level 440. If the cardiac signal amplitude falls within the threshold 440 during the first time interval 420, then the cardiac response is classified as noncapture and a backup pace 470 may be delivered. The backup pace 470 is typically a high energy pace that is delivered following a backup interval (BPI) 430. For example, the BPI 430 may include an interval of about 100 ms timed from the delivery of the primary pace 410.

The system may utilize one or more cardiac response detection windows 455, 456, 460, 461 as illustrated in FIG. 3. A cardiac pacing response method that discriminates non-captured intrinsic beats in accordance with embodiments of the invention involves determining if one or more peak values of the cardiac response signal falls, or does not fall, within one or more cardiac response detection windows 455, 456, 460, 461. In this embodiment, the cardiac response detection windows 455, 456, 460, 461 are areas defined in terms of amplitude and time. In other embodiments, different or additional parameters may be used in addition to, or in place of the parameters of amplitude and time.

In the example of FIG. 3, the system may classify a cardiac response as capture if a peak value of the cardiac signal is detected in the first capture detection window 455 and a peak value of the cardiac signal is detected in the second capture detection window 456. If a cardiac signal peak is detected in the first non-captured intrinsic detection window 460, or the second non-captured intrinsic detection window 461, the cardiac response may be classified as noncapture with non-captured intrinsic activation. Otherwise, the beat may be classified as a fusion/pseudofusion beat, or further discriminated.

Devices and methods that discriminate non-captured intrinsic beats during evoked response detection and classification in accordance with embodiments of the present invention may involve the use of one or more noise detection windows 435, 436 for further discrimination of cardiac waveforms. If signal peaks fall within the cardiac response classification windows 455, 456, 460, 461 then the system checks for peaks opposite in polarity and comparable in magnitude to the cardiac response signal peaks. FIG. 3 illustrates noise detection windows 435, 436. The noise detection windows 435, 436 may be any shape or size. For example, the noise detection windows 435, 436 may be the same size and/or shape as a corresponding capture detection window 455, 456 in a particular time interval 420, 450, or may be a different size and/or shape. Methods and systems involving noise detection windows, aspects of which may be utilized in connection with the embodiments of the present invention are described in commonly owned U.S. patent application identified by Attorney Docket Number GUID.171PA, concurrently filed with this patent application, and incorporated herein by reference.

FIG. 4 illustrates three representative cardiac response waveform portions superimposed over the graph illustrated in FIG. 3. A non-captured intrinsic beat 480, a PVC beat 482, and a captured beat 484 are drawn, illustrating waveform parameters useful for discriminating non-captured intrinsic beats during cardiac pacing response classification in accordance with the present invention. The waveform parameters of the PVC beat 482 illustrated in the graph of FIG. 4 include, but are not limited to, a negative peak amplitude 481 within the second noise detection window 436 during the second time interval 450, and a positive peak 489 within the first noise detection window 435 during the first time interval 420.

The waveform parameters of the non-captured intrinsic beat 480 illustrated in the graph of FIG. 4 include, but are not limited to, a negative peak amplitude 493 within the first intrinsic detection window 460. The waveform parameters of the captured beat 484 illustrated in the graph of FIG. 4 include, but are not limited to, a negative peak amplitude 487 within the first capture detection window 455 during the first time interval 420, and a positive peak 485 within the second capture detection window 456 during the second time interval 450.

As is evident in FIG. 4, the non-captured intrinsic beat 480 and the captured beat 484 have morphologies similar enough that they may be confused if discrimination of non-captured intrinsic beats during evoked response detection and classification is not performed in accordance with embodiments of the present invention.

First and second intrinsic detection windows 460, 461 are provided in accordance with embodiments of the present invention to perform intrinsic discrimination. In some scenarios, the non-captured intrinsic beat 480 has a greater negative peak amplitude than the captured beat 484. The second intrinsic detection window 461 is defined in both time duration and amplitude breadth to discriminate arrival of a non-captured intrinsic beat 480, having a relatively larger negative peak, within the time frame of the capture detection window 455.

In some scenarios, as illustrated by the intrinsic waveform 480 of FIG. 4, the negative peak 493 of the intrinsic beat occurs slightly later than the negative peak 487 of the captured beat signal 484. A first intrinsic detection window 460 that begins after the first capture detection window 455 discriminates intrinsic beats from capture beats. Providing one or more non-captured intrinsic beat capture detection windows in accordance with the present invention improves the discrimination capabilities of cardiac devices and reduces or eliminates the inclusion of undesired response signals during capture threshold testing, capture verification, template initialization and/or updating, and/or for other purposes when non-captured intrinsic beat discrimination is desirable.

The parameters of the intrinsic detection windows, including shape, area, and/or position may be selected based on the estimated or known morphology of cardiac signals associated with noncaptured intrinsic beats. Determination of the detection window parameters may be based on clinical data or on data acquired from the patient.

In one embodiment, the intrinsic detection window parameters are based on the relative timing of the capture detection window. Intrinsic activity generally occurs slightly later than the captured activity. Therefore, the intrinsic detection window may be arranged to occur just after the capture detection window, for example, in the first classification interval.

Patient conditions may affect the selected parameters of the intrinsic detection windows. For patients with intact AV conduction, for example, the intrinsic detection window parameters may be selected based on this information. In one implementation, for patients with known AV delay, the intrinsic detection window may be positioned to occur a predetermined time following atrial activity.

The embodiments of the present system illustrated herein are generally described as being implemented in a patient implantable medical device such as a pacemaker/defibrillator that may operate in numerous pacing modes known in the art. Various types of single and multiple chamber implantable cardiac defibrillators are known in the art and may be used in connection with cardiac devices and methods that discriminate non-captured intrinsic beats during evoked response detection and classification in accordance with the present invention. The methods of the present invention may also be implemented in a variety of implantable or patient-external cardiac rhythm management devices, including single and multi chamber pacemakers, defibrillators, cardioverters, bi-ventricular pacemakers, cardiac resynchronizers, and cardiac monitoring systems, for example.

Although the present system is described in conjunction with an implantable cardiac defibrillator having a microprocessor-based architecture, it will be understood that the implantable cardiac defibrillator (or other device) may be implemented in any logic-based integrated circuit architecture, if desired.

Referring now to FIG. 5 of the drawings, there is shown a cardiac rhythm management system that may be used to implement methods that discriminate non-captured intrinsic beats during evoked response detection and cardiac pacing response classification in accordance with the present invention. The cardiac rhythm management system in FIG. 5 includes a pacemaker/defibrillator 800 electrically and physically coupled to a lead system 802. The housing and/or header of the pacemaker/defibrillator 800 may incorporate one or more electrodes 908, 909 used to provide electrical stimulation energy to the heart and to sense cardiac electrical activity. The pacemaker/defibrillator 800 may utilize all or a portion of the pacemaker/defibrillator housing as a can electrode 909. The pacemaker/defibrillator 800 may include an indifferent electrode 908 positioned, for example, on the header or the housing of the pacemaker/defibrillator 800. If the pacemaker/defibrillator 800 includes both a can electrode 909 and an indifferent electrode 908, the electrodes 908, 909 typically are electrically isolated from each other.

The lead system 802 is used to detect electric cardiac signals produced by the heart 801 and to provide electrical energy to the heart 801 under certain predetermined conditions to treat cardiac arrhythmias. The lead system 802 may include one or more electrodes used for pacing, sensing, and/or defibrillation. In the embodiment shown in FIG. 5, the lead system 802 includes an intracardiac right ventricular (RV) lead system 804, an intracardiac right atrial (RA) lead system 805, an intracardiac left ventricular (LV) lead system 806, and an extracardiac left atrial (LA) lead system 808. The lead system 802 of FIG. 5 illustrates one embodiment that may be used in connection with the feature determination methodologies described herein. Other leads and/or electrodes may additionally or alternatively be used.

The lead system 802 may include intracardiac leads 804, 805, 806 implanted in a human body with portions of the intracardiac leads 804, 805, 806 inserted into a heart 801. The intracardiac leads 804, 805, 806 include various electrodes positionable within the heart for sensing electrical activity of the heart and for delivering electrical stimulation energy to the heart, for example, pacing pulses and/or defibrillation shocks to treat various arrhythmias of the heart.

As illustrated in FIG. 5, the lead system 802 may include one or more extracardiac leads 808 having electrodes, e.g., epicardial electrodes, positioned at locations outside the heart for sensing and pacing one or more heart chambers.

The right ventricular lead system 804 illustrated in FIG. 5 includes an SVC-coil 816, an RV-coil 814, an RV-ring electrode 811, and an RV-tip electrode 812. The right ventricular lead system 804 extends through the right atrium 820 and into the right ventricle 819. In particular, the RV-tip electrode 812, RV-ring electrode 811, and RV-coil electrode 814 are positioned at appropriate locations within the right ventricle 819 for sensing and delivering electrical stimulation pulses to the heart 801. The SVC-coil 816 is positioned at an appropriate location within the right atrium chamber 820 of the heart 801 or a major vein leading to the right atrial chamber 820 of the heart 801.

In one configuration, the RV-tip electrode 812 referenced to the can electrode 909 may be used to implement unipolar pacing and/or sensing in the right ventricle 819. Bipolar pacing and/or sensing in the right ventricle may be implemented using the RV-tip 812 and RV-ring 811 electrodes. In yet another configuration, the RV-ring 811 electrode may optionally be omitted, and bipolar pacing and/or sensing may be accomplished using the RV-tip electrode 812 and the RV-coil 814, for example. The RV-coil 814 and the SVC-coil 816 are defibrillation electrodes.

The left ventricular lead 806 includes an LV distal electrode 813 and an LV proximal electrode 817 located at appropriate locations in or about the left ventricle 824 for pacing and/or sensing the left ventricle 824. The left ventricular lead 806 may be guided into the right atrium 820 of the heart via the superior vena cava. From the right atrium 820, the left ventricular lead 806 may be deployed into the coronary sinus ostium, the opening of the coronary sinus 850. The lead 806 may be guided through the coronary sinus 850 to a coronary vein of the left ventricle 824. This vein is used as an access pathway for leads to reach the surfaces of the left ventricle 824 which are not directly accessible from the right side of the heart. Lead placement for the left ventricular lead 806 may be achieved via subclavian vein access and a preformed guiding catheter for insertion of the LV electrodes 813, 817 adjacent to the left ventricle.

Unipolar pacing and/or sensing in the left ventricle may be implemented, for example, using the LV distal electrode referenced to the can electrode 909. The LV distal electrode 813 and the LV proximal electrode 817 may be used together as bipolar sense and/or pace electrodes for the left ventricle. The left ventricular lead 806 and the right ventricular lead 804, in conjunction with the pacemaker/defibrillator 800, may be used to provide cardiac resynchronization therapy such that the ventricles of the heart are paced substantially simultaneously, or in phased sequence, to provide enhanced cardiac pumping efficiency for patients suffering from chronic heart failure.

The right atrial lead 805 includes a RA-tip electrode 856 and an RA-ring electrode 854 positioned at appropriate locations in the right atrium 820 for sensing and pacing the right atrium 820. In one configuration, the RA-tip 856 referenced to the can electrode 909, for example, may be used to provide unipolar pacing and/or sensing in the right atrium 820. In another configuration, the RA-tip electrode 856 and the RA-ring electrode 854 may be used to provide bipolar pacing and/or sensing.

FIG. 5 illustrates one embodiment of a left atrial lead system 808. In this example, the left atrial lead 808 is implemented as an extracardiac lead with LA distal 818 and LA proximal 815 electrodes positioned at appropriate locations outside the heart 801 for sensing and pacing the left atrium 822. Unipolar pacing and/or sensing of the left atrium may be accomplished, for example, using the LA distal electrode 818 to the can 909 pacing vector. The LA proximal 815 and LA distal 818 electrodes may be used together to implement bipolar pacing and/or sensing of the left atrium 822.

Referring now to FIG. 6, there is shown an embodiment of a cardiac pacemaker/defibrillator 900 suitable for implementing non-captured intrinsic cardiac response detection and classification methods of the present invention. FIG. 6 shows a cardiac pacemaker/defibrillator 900 divided into functional blocks. It is understood by those skilled in the art that there exist many possible configurations in which these functional blocks can be arranged. The example depicted in FIG. 6 is one possible functional arrangement. Other arrangements are also possible. For example, more, fewer or different functional blocks may be used to describe a cardiac pacemaker/defibrillator suitable for implementing the methodologies for feature determination in accordance with the present invention. In addition, although the cardiac pacemaker/defibrillator 900 depicted in FIG. 6 contemplates the use of a programmable microprocessor-based logic circuit, other circuit implementations may be utilized.

The cardiac pacemaker/defibrillator 900 depicted in FIG. 6 includes circuitry for receiving cardiac signals from a heart and delivering electrical stimulation energy to the heart in the form of pacing pulses or defibrillation shocks. In one embodiment, the circuitry of the cardiac pacemaker/defibrillator 900 is encased and hermetically sealed in a housing 901 suitable for implanting in a human body. Power to the cardiac pacemaker/defibrillator 900 is supplied by an electrochemical battery 980. A connector block (not shown) is attached to the housing 901 of the cardiac pacemaker/defibrillator 900 to allow for the physical and electrical attachment of the lead system conductors to the circuitry of the cardiac pacemaker/defibrillator 900.

The cardiac pacemaker/defibrillator 900 may be a programmable microprocessor-based system, including a control system 920 and a memory 970. The memory 970 may store parameters for various pacing, defibrillation, and sensing modes, along with other parameters. Further, the memory 970 may store data indicative of cardiac signals received by other components of the cardiac pacemaker/defibrillator 900. The memory 970 may be used, for example, for storing historical EGM and therapy data. The historical data storage may include, for example, data obtained from long-term patient monitoring used for trending and/or other diagnostic purposes. Historical data, as well as other information, may be transmitted to an external programmer unit 990 as needed or desired.

The control system 920 and memory 970 may cooperate with other components of the cardiac pacemaker/defibrillator 900 to control the operations of the cardiac pacemaker/defibrillator 900. The control system depicted in FIG. 5 incorporates a cardiac response classification processor 925 for classifying cardiac responses to pacing stimulation. The cardiac response classification processor performs the function of discriminating non-captured intrinsic responses for pacing response classification in accordance with embodiments of the invention. The control system 920 may include additional functional components including a pacemaker control circuit 922, an arrhythmia detector 921, along with other components for controlling the operations of the cardiac pacemaker/defibrillator 900.

Telemetry circuitry 960 may be implemented to provide communications between the cardiac pacemaker/defibrillator 900 and an external programmer unit 990. In one embodiment, the telemetry circuitry 960 and the programmer unit 990 communicate using a wire loop antenna and a radio frequency telemetric link, as is known in the art, to receive and transmit signals and data between the programmer unit 990 and the telemetry circuitry 960. In this manner, programming commands and other information may be transferred to the control system 920 of the cardiac pacemaker/defibrillator 900 from the programmer unit 990 during and after implant. In addition, stored cardiac data pertaining to capture threshold, capture detection and/or cardiac response classification, for example, along with other data, may be transferred to the programmer unit 990 from the cardiac pacemaker/defibrillator 900.

The telemetry circuitry 960 may provide for communication between the cardiac pacemaker/defibrillator 900 and an advanced patient management (APM) system. The advanced patient management system allows physicians or other personnel to remotely and automatically monitor cardiac and/or other patient conditions. In one example, a cardiac pacemaker/defibrillator, or other device, may be equipped with various telecommunications and information technologies that enable real-time data collection, diagnosis, and treatment of the patient. Various embodiments described herein may be used in connection with advanced patient management. Methods, structures, and/or techniques described herein, which may be adapted to provide for remote patient/device monitoring, diagnosis, therapy, or other APM related methodologies, may incorporate features of one or more of the following references: U.S. Pat. Nos. 6,221,011; 6,270,457; 6,277,072; 6,280,380; 6,312,378; 6,336,903; 6,358,203; 6,368,284; 6,398,728; and 6,440,066, which are hereby incorporated herein by reference.

In the embodiment of the cardiac pacemaker/defibrillator 900 illustrated in FIG. 5, electrodes RA-tip 856, RA-ring 854, RV-tip 812, RV-ring 811, RV-coil 814, SVC-coil 816, LV distal electrode 813, LV proximal electrode 817, LA distal electrode 818, LA proximal electrode 815, indifferent electrode 908, and can electrode 909 are coupled through a switch matrix 910 to sensing circuits 931-937.

A right atrial sensing circuit 931 serves to detect and amplify electrical signals from the right atrium of the heart. Bipolar sensing in the right atrium may be implemented, for example, by sensing voltages developed between the RA-tip 856 and the RA-ring 854. Unipolar sensing may be implemented, for example, by sensing voltages developed between the RA-tip 856 and the can electrode 909. Outputs from the right atrial sensing circuit are coupled to the control system 920.

A right ventricular sensing circuit 932 serves to detect and amplify electrical signals from the right ventricle of the heart. The right ventricular sensing circuit 932 may include, for example, a right ventricular rate channel 933 and a right ventricular shock channel 934. Right ventricular cardiac signals sensed through use of the RV-tip 812 electrode are right ventricular near-field signals and are denoted RV rate channel signals. A bipolar RV rate channel signal may be sensed as a voltage developed between the RV-tip 812 and the RV-ring 811. Alternatively, bipolar sensing in the right ventricle may be implemented using the RV-tip electrode 812 and the RV-coil 814. Unipolar rate channel sensing in the right ventricle may be implemented, for example, by sensing voltages developed between the RV-tip 812 and the can electrode 909.

Right ventricular cardiac signals sensed through use of the defibrillation electrodes are far-field signals, also referred to as RV morphology or RV shock channel signals. More particularly, a right ventricular shock channel signal may be detected as a voltage developed between the RV-coil 814 and the SVC-coil 816. A right ventricular shock channel signal may also be detected as a voltage developed between the RV-coil 814 and the can electrode 909. In another configuration the can electrode 909 and the SVC-coil electrode 816 may be electrically shorted and a RV shock channel signal may be detected as the voltage developed between the RV-coil 814 and the can electrode 909/SVC-coil 816 combination.

Outputs from the right ventricular sensing circuit 932 are coupled to the control system 920. In one embodiment of the invention, rate channel signals and shock channel signals may be used to develop morphology templates for analyzing cardiac signals. In this embodiment, rate channel signals and shock channel signals may be transferred from the right ventricular sensing circuit 932 to the control system 920 and analyzed for arrhythmia detection.

Left atrial cardiac signals may be sensed through the use of one or more left atrial electrodes 815, 818, which may be configured as epicardial electrodes. A left atrial sensing circuit 935 serves to detect and amplify electrical signals from the left atrium of the heart. Bipolar sensing and/or pacing in the left atrium may be implemented, for example, using the LA distal electrode 818 and the LA proximal electrode 815. Unipolar sensing and/or pacing of the left atrium may be accomplished, for example, using the LA distal electrode 818 to can vector 909 or the LA proximal electrode 815 to can vector 909.

A left ventricular sensing circuit 936 serves to detect and amplify electrical signals from the left ventricle of the heart. Bipolar sensing in the left ventricle may be implemented, for example, by sensing voltages developed between the LV distal electrode 813 and the LV proximal electrode 817. Unipolar sensing may be implemented, for example, by sensing voltages developed between the LV distal electrode 813 or the LV proximal electrode 817 and the can electrode 909.

Optionally, an LV coil electrode (not shown) may be inserted into the patient's cardiac vasculature, e.g., the coronary sinus, adjacent the left heart. Signals detected using combinations of the LV electrodes, 813, 817, LV coil electrode (not shown), and/or can electrodes 909 may be sensed and amplified by the left ventricular sensing circuitry 936. The output of the left ventricular sensing circuit 936 is coupled to the control system 920.

The outputs of the switching matrix 910 may be operated to couple selected combinations of electrodes 811, 812, 813, 814, 815, 816, 817, 818, 856, 854 to an evoked response sensing circuit 937. The evoked response sensing circuit 937 serves to sense and amplify voltages developed using various combinations of electrodes for discrimination of various cardiac responses to pacing in accordance with embodiments of the invention. The cardiac response classification processor 925 may analyze the output of the evoked response sensing circuit 937 to implement feature association and cardiac pacing response classification in accordance with embodiments of the invention.

Various combinations of pacing and sensing electrodes may be utilized in connection with pacing and sensing the cardiac signal following the pace pulse to classify the cardiac response to the pacing pulse. For example, in some embodiments, a first electrode combination is used for pacing a heart chamber and a second electrode combination is used to sense the cardiac signal following pacing. In other embodiments, the same electrode combination is used for pacing and sensing. Use of different electrodes for pacing and sensing in connection with capture verification is described in commonly owned U.S. Pat. No. 6,128,535 which is incorporated herein by reference.

The pacemaker control circuit 922, in combination with pacing circuitry for the left atrium, right atrium, left ventricle, and right ventricle 941, 942, 943, 944, may be implemented to selectively generate and deliver pacing pulses to the heart using various electrode combinations. The pacing electrode combinations may be used to effect bipolar or unipolar pacing pulses to a heart chamber using one of the pacing vectors as described above. In some implementations, the cardiac pacemaker/defibrillator 900 may include a sensor 961 that is used to sense the patient's hemodynamic need. The pacing output of the cardiac pacemaker/defibrillator may be adjusted based on the sensor 961 output.

The electrical signal following the delivery of the pacing pulses may be sensed through various sensing vectors coupled through the switch matrix 910 to the evoked response sensing circuit 937 and used to classify the cardiac response to pacing. The cardiac response may be classified as one of a captured response, a non-captured response, a non-captured response with intrinsic activation, and a fusion/pseudofusion beat, for example.

Subcutaneous electrodes may provide additional sensing vectors useable for cardiac response classification. In one implementation, cardiac rhythm management system may involve a hybrid system including an intracardiac device configured to pace the heart and an extracardiac device, e.g., a subcutaneous defibrillator, configured to perform functions other than pacing. The extracardiac device may be employed to detect and classify cardiac response to pacing based on signals sensed using subcutaneous electrode arrays. The extracardiac and intracardiac devices may operate cooperatively with communication between the devices occurring over a wireless link, for example. Examples of subcutaneous electrode systems and devices are described in commonly owned U.S. patent application Ser. No. 10/462,001, filed Jun. 13, 2003 and Ser. No. 10/465,520, filed Jun. 19, 2003, which are hereby incorporated herein by reference in their respective entireties.

FIG. 7 illustrates a block diagram of circuit 995 that may be used to sense cardiac signals following the delivery of a pacing stimulation and classify the cardiac response to the pacing stimulation according to embodiments of the invention. A switch matrix 984 is used to couple the cardiac electrodes 971, 972 in various combinations discussed above to the sensing portion 970 of the cardiac response classification circuit 995. The sensing portion 970 includes filtering and blanking circuitry 975, 977, sense amplifier 985, band pass filter 981, and window generation and signal characteristic detector 982. The window generation and signal characteristic detector 982 is coupled to a cardiac response classification processor 983.

A control system, e.g., the control system 920 depicted in FIG. 6, is operatively coupled to components of the cardiac sensing circuit 995 and controls the operation of the circuit 995, including the filtering and blanking circuits 975, 977. Following delivery of the pacing stimulation, the blanking circuitry 975, 977 operates for a sufficient duration and then allows detection of a cardiac signal responsive to the pacing stimulation. The cardiac signal is filtered, amplified, and converted from analog to digital form. The digitized signal is communicated to the cardiac response classification processor 983, which operates in cooperation with other components of the control system 920 (FIG. 6) to classify cardiac responses to pacing according to embodiments of the invention.

Various modifications and additions can be made to the preferred embodiments discussed hereinabove without departing from the scope of the present invention. Accordingly, the scope of the present invention should not be limited by the particular embodiments described above, but should be defined only by the claims set forth below and equivalents thereof.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7647108Sep 30, 2004Jan 12, 2010Cardiac Pacemakers, Inc.Methods and systems for selection of cardiac pacing electrode configurations
US7761162 *Dec 13, 2004Jul 20, 2010Cardiac Pacemakers, Inc.Capture verification with intrinsic response discrimination
US7778696 *Nov 21, 2005Aug 17, 2010Cardiac Pacemakers, Inc.Selection of cardiac capture verification modes
US7801610Nov 17, 2006Sep 21, 2010Cardiac Pacemakers, Inc.Methods and systems for management of atrial retrograde conduction and pacemaker mediated tachyarrhythmia
US7957803Aug 13, 2009Jun 7, 2011Cardiac Pacemakers, Inc.Atrial capture verification
US8155741Nov 21, 2008Apr 10, 2012Cardiac Pacemakers, Inc.Retrograde atrial sensing for identifying sub-threshold atrial pacing
US8229561Dec 15, 2004Jul 24, 2012Cardiac Pacemakers, Inc.Atrial retrograde management
US8280509Jul 30, 2010Oct 2, 2012Cardiac Pacemakers, Inc.Selection of cardiac capture verification modes
US8290590Nov 17, 2006Oct 16, 2012Cardiac Pacemakers, Inc.Dynamic morphology based atrial automatic threshold
US8452405May 3, 2010May 28, 2013Cardiac Pacemakers, Inc.Methods and systems for mitigating the occurrence of arrhythmia during atrial pacing
EP2756865A1 *Jan 20, 2014Jul 23, 2014BIOTRONIK SE & Co. KGDevice and method for fusion beat detection
WO2008063492A1 *Nov 15, 2007May 29, 2008Cardiac Pacemakers IncDynamic morphology based atrial automatic threshold
Classifications
U.S. Classification607/9
International ClassificationA61N1/362
Cooperative ClassificationA61N1/371
European ClassificationA61N1/37D
Legal Events
DateCodeEventDescription
Jun 22, 2005ASAssignment
Owner name: CARDIAC PACEMAKERS, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DONG, YANTING;MEYER, SCOTT A.;STALSBERG, KEVIN JOHN;REEL/FRAME:016385/0862;SIGNING DATES FROM 20050415 TO 20050421